Patent · US Active

Use of fibroblast growth factor 2

US10493129B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY · CN

Inventors

Xiliang Wang · Beijing, CN
Chengyu JIANG · Beijing, CN
Penghui Yang · Beijing, CN
Xin Liu · Wuxi, CN
Yueqiang Duan · Beijing, CN
Li Xing · Lexington, US
Chengcai Lai · Beijing, CN

Key dates

Filing date	Aug 9, 2013
Grant date	Dec 3, 2019
Priority date	—
Expiry date	Aug 9, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a novel use of fibroblast growth factor 2 (FGF-2), i.e., a use of FGF-2 in preparation of medicine. The uses of the medicine are the following (a) and/or (b) and/or (c): (a) the prevention and/or treatment of lung injury; (b) the prevention and/or treatment of influenza; (c) the prevention and/or treatment of diseases caused by influenza viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.